DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zofran (Ondansetron) - Left Atrial Dilatation - Suspected Cause - Side Effect Reports


Index of reports > Cases with Left Atrial Dilatation ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zofran (Ondansetron) where reactions include left atrial dilatation. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Zofran side effects in female

Reported by a individual with unspecified qualification from United States on 2012-01-18

Patient: female

Reactions: Tooth Loss, Abdominal Pain, Pruritus, Eczema, Oral Discomfort, Rheumatoid Arthritis, DRY Mouth, Oedema Peripheral, Ileitis, Vertebral Foraminal Stenosis, Back Pain, Melanosis Coli, Osteopenia, Bursitis, Respiratory Tract Congestion, Diverticulum, Increased Tendency To Bruise, Vision Blurred, Left Atrial Dilatation, Abscess, Pyoderma Gangrenosum, Fall, Dermatitis Contact, Intertrigo, Vitreous Floaters, Conjunctivochalasis, Obesity, Rotator Cuff Syndrome, Dyspnoea, Cataract, Excoriation, Joint Dislocation, Varicose Ulceration, Ulnar Neuritis, Syncope, Visual Impairment, Loose Tooth, Gait Disturbance, DRY Eye, Urinary Incontinence, Dementia, Flatulence, Lumbar Spinal Stenosis, Dyspepsia, Electrocardiogram T Wave Abnormal, Ingrowing Nail, Resorption Bone Increased, Radiculopathy, General Physical Health Deterioration, Venous Insufficiency, Hypoaesthesia, Ankle Fracture, Osteonecrosis, Wound Infection Pseudomonas, Joint Swelling, Insomnia, Otitis Media, Colitis, Glaucoma, Pain, Constipation, Gastritis, Fatigue, Bone Loss, Road Traffic Accident, Skin Ulcer, Corneal Dystrophy, Glare, Microangiopathy, Gastrooesophageal Reflux Disease, Pain in JAW, Abdominal Pain Lower, Vulvovaginal Mycotic Infection, Hyponatraemia, Cystitis, Varicose Vein, Facial Pain, Mucosal Inflammation, Anxiety, Diarrhoea, Osteonecrosis of JAW, Deep Vein Thrombosis, Inflammatory Bowel Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
    Dosage: 4 mg, daily
    Indication: Osteoporosis
    Start date: 2005-07-12
    End date: 2006-07-06

    Dosage: 3.3 mg, unk

    Dosage: 4 mg/2ml, q8h

Other drugs received by patient: Dapsone; Keflex; Vicodin; Meperidine HCL; Imodium; Diovan; Miconazole Nitrate; Clonidine Hydrochloride; Protonix; Omeprazole; Clindamycin; Meclizine; Toradol; Ciprofloxacin; Docusate; Arimidex; Effexor; Gabapentin; Ambien; Citalopram Hydrochloride; Univasc; Triamterene and Hydrochlorothiazide; Furosemide; Venlafaxine; Depo-Medrol; Vytone; Chlordiazepoxide W / Clidinium Bromide; Mobic; Phenergan; Clinoril; Quinine Sulfate; Diphenhydramine HCL; Mytussin DAC; Cephalexin; Norvasc; Diphenoxylate HCL and Atropine Sulfate; Orphenadrine Citrate; Aricept; Acetaminophen and Hydrocodone Bitartrate; Prochlorperazine; Atenolol; Fluoxetine; Spironolactone; Sulindac; Hydrocortisone; Mirapex; Benicar; Compazine; Ancef; Percocet; Naproxen; Sucralfate; Ultram; Desoximetasone; Metoprolol; Orphenadrine Citrate; Tramadol HCL; Nexium; Amoxicillin and Clavulanate Potassium; Lisinopril; Pepcid; Cyclobenzaprine HCL; Miralax; Armodafinil

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017